Postural Orthostatic Tachycardia Syndrome Clinical Trial
Official title:
Mechanism of Chemoreflex and Baroreflex Alterations Causing Postural Tachycardia Syndrome in POTS Patients With Orthostatic Hyperpnea and Hypocapnia
Postural tachycardia syndrome (POTS) is the most common chronic cause of postural lightheadedness, and upright confusion afflicting many Americans, mostly young women. Many POTS patients hyperventilate by increasing their depth of breathing that produces tachycardia, alters blood flow and blood pooling in the body and importantly reduces brain blood flow causing "brain fog". In this proposal the investigators will demonstrate in young women that abnormal repeated brief impairment of blood pressure and brain flow just after standing sensitizes the body's oxygen sensor in POTS to respond as if it were in a low oxygen environment causing hyperventilation and its consequences. In this project the investigators will use various drugs that will help to understand the mechanisms that cause POTS in this unique subset of POTS patients who hyperventilate.
The Investigators will compare results from female POTS patients, free of known pulmonary or sleep disorders aged 15 to 39 years with, and without orthostatic hyperpneic hypocapnia, to healthy female volunteers with the following two (2) specific aims: 1. To test poikilocapnic (allowing carbon dioxide (CO2) to vary) orthostatic cardiorespiratory responses to determine whether prolonged initial orthostatic hypotension (IOH) precedes upright hypocapnia in hyperpneic POTS but not in controls or non-hyperpneic POTS. Subjects are instrumented for cerebral blood flow, respiratory and hemodynamic measurements, investigating splanchnic blood flow by indocyanine green infusion, and measuring changes of CBV, regional blood volumes, and cardiac output (CO) by impedance plethysmography during a 10 min stand to quantify IOH, and a 10 min tilt test to 70⁰ to quantitate cardiorespiratory changes. These changes during tilt stratify hyperpneic and non-hyperpneic POTS. 2. To test if chemoreflex sensitization of ventilation and sympathetic activity (by microneurography) are abnormal when supine and tilted upright at 45o and how that interacts with Oxford measured cardiovagal and sympathetic baroreflexes under controlled gas conditions which are: isocapnic hypoxia and isocapnic hyperoxia to measure carotid body reflex; hyperoxic isocapnia and hyperoxic hypercapnia to measure central chemoreflexes. Hyperoxia silences peripheral chemoreceptors and will normalize baroreflex and tilt responses. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05555771 -
Paediatric Syncope in the Emergency Department
|
N/A | |
Completed |
NCT05633407 -
Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS
|
Phase 2 | |
Completed |
NCT03930914 -
Vagus Nerve Stimulation in Treatment of Postural Orthostatic Tachycardia Syndrome
|
N/A | |
Recruiting |
NCT00865917 -
Cardiovascular Effects of Selective I(f)-Channel Blockade
|
Phase 2 | |
Recruiting |
NCT05741112 -
The Long COVID-19 Wearable Device Study
|
N/A | |
Recruiting |
NCT05454137 -
A Shared Medical Appointment Intervention for Quality of Life Improvement in POTS
|
N/A | |
Recruiting |
NCT05924646 -
CAlgary SAlt for POTS
|
N/A | |
Enrolling by invitation |
NCT05877534 -
Effects of Individual Tailored Physical Exercise in Patients With POTS After COVID-19 - a Randomized Controlled Study
|
N/A | |
Completed |
NCT01367977 -
Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life
|
||
Recruiting |
NCT04881318 -
Compression Garments in the Community With POTS
|
N/A | |
Recruiting |
NCT06292104 -
Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)
|
||
Completed |
NCT02171988 -
Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
|
Phase 4 | |
Completed |
NCT01563107 -
Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome
|
N/A | |
Completed |
NCT01547117 -
Dietary Salt in Postural Tachycardia Syndrome
|
N/A | |
Completed |
NCT01617616 -
Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects
|
N/A | |
Active, not recruiting |
NCT02281097 -
Transdermal Vagal Stimulation for POTS
|
N/A | |
Completed |
NCT00728026 -
Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea
|
N/A | |
Recruiting |
NCT05481177 -
Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort
|
Phase 4 | |
Not yet recruiting |
NCT05914649 -
NC Testing in LC & POTS
|
N/A | |
Completed |
NCT05404672 -
Breathing Exercises With And Without Aerobic Training In Patients With Postural Orthostatic Tachycardia Syndrome
|
N/A |